AI Integration And Global Biologics Demand Will Reshape Antibody Discovery
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
10 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$11.00
81.7% undervalued intrinsic discount16 Aug
US$2.01
1Y
-52.3%7D
2.6%